Overview Multiple-Ascending Dose Study Status: Completed Trial end date: 2010-11-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the safety and tolerability of BMS-820836 after multiple doses Phase: Phase 1 Details Lead Sponsor: Bristol-Myers Squibb